LSC - 2018 - Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension

S. Collum, T. Weng (Tingting.Weng@uth.tmc.edu / UTHealth,Houston), A. Hernandez (Adriana.M.Hernandez@uth.tmc.edu / UTHealth,Houston), T. Mertens (Tinne.C.Mertens@uth.tmc.edu / UTHealth,Houston), N. Chen (Ning-Yuan.Chen@uth.tmc.edu / UTHealth,Houston), A. Guha (gashrith@houstonmethodist.org / Debakey Heart & Vascular Center,Houston), K. Youker (kayouker@houstonmethodist.org / Debakey Heart & Vascular Center,Houston), E. Wagner (ejwagner@UTMB.EDU / UTMB,Galveston), L. Han (Leng.Han@uth.tmc.edu / UTHealth,Houston), M. Blackburn (Michael.R.Blackburn@uth.tmc.edu / UTHealth,Houston), H. Karmouty-Quintana (Harry.Karmouty@uth.tmc.edu / UTHealth,Houston)

Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Session: Pathobiology of pulmonary hypertension
Session type: Poster Discussion
Number: 3922
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Collum, T. Weng (Tingting.Weng@uth.tmc.edu / UTHealth,Houston), A. Hernandez (Adriana.M.Hernandez@uth.tmc.edu / UTHealth,Houston), T. Mertens (Tinne.C.Mertens@uth.tmc.edu / UTHealth,Houston), N. Chen (Ning-Yuan.Chen@uth.tmc.edu / UTHealth,Houston), A. Guha (gashrith@houstonmethodist.org / Debakey Heart & Vascular Center,Houston), K. Youker (kayouker@houstonmethodist.org / Debakey Heart & Vascular Center,Houston), E. Wagner (ejwagner@UTMB.EDU / UTMB,Galveston), L. Han (Leng.Han@uth.tmc.edu / UTHealth,Houston), M. Blackburn (Michael.R.Blackburn@uth.tmc.edu / UTHealth,Houston), H. Karmouty-Quintana (Harry.Karmouty@uth.tmc.edu / UTHealth,Houston). LSC - 2018 - Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension. 3922

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension
Source: ERS Lung Science Conference 2018
Year: 2018

LSC - 2018 - Physical and biochemical interactions drive fibrocytes accumulation in the scleroderma lung matrix
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018


LATE-BREAKING ABSTRACT: Fibroblast conditioned matrix: A new approach to study extracellular matrix (ECM) effects in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016


LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018

Extracellular matrix (ECM) proteins in airway and in COPD mice: regional expression difference and potential mechanism mediated by TGF-ß1.
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012



LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019



Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD?
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015

A potential role for extracellular matrix proteins in lung ageing in COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced idiopathic pulmonary fibrosis by regulation of extracellular matrix remodelling
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

LSC - 2021 - SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Role of endothelin in lung fibrosis
Source: Eur Respir Rev 2008; 17: 145-150
Year: 2008



Extracellular matrix composition in COPD
Source: Eur Respir J 2012; 40: 1362-1373
Year: 2012